R. Schermuly (Giessen, Germany), N. Galie (Bologna, Italy)
Hypoxia-induced pulmonary hypertension: Synergistic effects of sildenafil and erythropoietin in mice
V. Samillan, T. Haider, J. Vogel, M. Gassmann, L. Ostergaard (Switzerland)
|   |
Myocardial prostacyclin effects in experimental acute afterload-induced right ventricular failure
C. Dewachter, L. Dewachter, M. Vercruyssen, B. Rondelet, D.P. Schraufnagel, S. Brimioulle, F. Kerbaul, R. Naeije (Brussels, Belgium)
| |
Screening for biomarkers in pulmonary hypertension
S.L. Tiede, S.S. Pullamsetti, A. Sydykov, G. Lochnit, H. Tiede, H.A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, R.T. Schermuly (Bad Nauheim, Giessen, Germany)
| |
Effects of soluble guanylate cyclase (sGC) stimulation in guinea pigs chronically exposed to cigarette smoke
B. Lobo, R. Puig-Pey, E. Ferrer, D. Dominguez, N. Coll, J. García, V.I. Peinado, J.A. Barberà (Barcelona, Spain)
| |
Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model
L. Farkas, D. Farkas, D. Kraskauskas, A. Alhussaini, V. Kraskauskiene, H. Bogaard, N. Voelkel (Richmond, United States Of America; Amsterdam, Netherlands)
| |
Effect of long-term imatinib treatment in a severe preclinical PAH rat model: An insight into pulmonary perfusion using a novel casting method
O. Bonneau, N. Duggan, M. Hussey, L. Ciuclan, C. Tomlins, S. Roberts, L.D. Dang, R. Allen, D. Rowlands, M. Thomas (Horsham, United Kingdom)
| |
Cell cooperation between human fibrocytes and endothelial progenitor cells during neoangiogenesis is driven by the CXCR4 pathway
D. Smadja, P. Gaussem, P. Dorfmuller, I. Bieche, M. Kambouchner, E. Boscolo, M. Humbert, J. Bischoff, D. Israel-Biet (Le Plessis-Robinson, Bobigny, France; Boston, United States Of America)
| |
miR 16 modulates human pulmonary artery smooth muscle cell phenotype
P. Tamarapu parthasarathy, G. Kollongod Ramanathan, R.F. Lockey, N. Kolliputi (Tampa, United States Of America)
| |
Macrophage migration inhibitory factor (MIF) promoter polymorphisms are associated with favorable hemodynamic indices in systemic sclerosis-associated pulmonary arterial hypertension
T. Kolb, D. Boyce, N. Lechtzin, N. Rafaels, L. Gao, K. Barnes, R. Girgis, A. Zaiman, S. Mathai, L. Hummers, T. Housten, R. Damico, P. Hassoun (Baltimore, United States Of America)
| |
Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells
L. Price, F. Perros, D. Shao, J. Zhu, D. Montani, P. Dorfmuller, J. Wharton, M. Humbert, I. Adcock, J. Wort (London, United Kingdom; Clamart, Paris, France)
| |
Exogenous BMPR2 modulates TGF-β signalling in human small airway epithelium and smooth muscle cells
F. Feng, P. N. Reynolds (Adelaide, Australia)
| |
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
S. Rain, M.L. Handoko, N. Westerhof, C. dos Remedios, M. Humbert, P. Dorfmuller, C. Guignabert, A. Vonk-Noordegraaf, J. van der Velden, F.S. de Man (Amsterdam, Netherlands; Sydney, Australia; Paris, France)
| |
BMPR2 gene delivery shifts intracellular Smad activation profile
R. Harper, P. Reynolds, A. Reynolds (Adelaide, Australia)
| |
The role of bromodomain-containing protein 4 in the constitutive activation of nuclear factor-kappa B in endothelial cells from patients with pulmonary arterial hypertension
N. Gambaryan, C. Guignabert, L. Tu, F. Perros, I. Adcock, M. Humbert, S. Wort (Le Plessis-Robinson, France; London, United Kingdom)
| |
The combined therapy of HGF and G-CSF for pulmonary hypertension in rats
Y. Guo, L. Su, Y. Li, N. Guo, C. Liu (Beijing, China)
| |
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents
L. Tu, F. de Man, B. Girerd, M.C. Chaumais, F. Lecerf, C. Francois, F. Perros, P. Dorfmuller, E. Fadel, D. Montani, M. Humbert, E. Saadia, C. Guignabert (Le Plessis-Robinson, Orsay, Clamart, France; Amsterdam, Netherlands)
| |